Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy · Terms of Service · Privacy FAQ

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Transfyr

Transfyr

Transfyr builds physical AI systems that capture scientific lab work as machine-readable records.

HQ

Cambridge, MA, US

Founded

Transfyr is a Cambridge, Massachusetts company that brings AI to the physical work of science. Its sensor stack and multimodal models capture operator actions, environmental context, and instrument telemetry so laboratories can reduce process variance, transfer protocols reliably, and train people and robots from grounded execution data.

Co-founded by Anna Marie Wagner and Renee Wegrzyn, Transfyr partners with diagnostics, pharmaceutical, academic, robotics, and frontier AI organizations. The company launched publicly with a General Catalyst-led seed round and operates from The Engine in Cambridge with an in-house wet lab that generates training data and evaluates scientific AI systems.

Transfyr - Products & Services

Physical AI Platform
Physical AI platform that captures scientific lab execution as machine-readable records.

Transfyr - Similar Companies

Lila Sciences

lila.ai

Aether AI

aetherlabs.ai

Fluidize

fluidize.ai

Mithrl

mithrl.com

XDOF

xdof.ai

Inherent

inherentlabs.ai

Sapio Sciences

sapiosciences.com

Human Archive

humanarchive.ai

Physical Intelligence

AMI Labs

amilabs.xyz

Thinking Machines Lab

Strateos

strateos.com

Centific

centific.com

Shifters

shiftersai.com

Humigent

humigent.ai

Transfyr - Quick Facts

Who are Transfyr's competitors?

Companies similar to Transfyr include Lila Sciences, Aether AI, Fluidize and Mithrl.

When was Transfyr founded?

Transfyr was founded in 2025.

Where is Transfyr's headquarters located?

Transfyr's headquarters is located in Cambridge, MA, US.

When was Transfyr's last funding round?

Transfyr's most recent funding round was for $25M (USD) in August 2026.

How much has Transfyr raised to-date?

As of Aug 26, 2026, Transfyr has raised a total of $25M (USD).

Transfyr - Classification

Ownership: Venture-backed private company
Technology: AI Machine Learning

Revenue: B2B

Tags: AI
Deep Tech
Life Sciences